nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—OPRM1—telencephalic ventricle—bipolar disorder	0.0464	0.264	CbGeAlD
Levomethadyl Acetate—CHRNB4—nervous system—bipolar disorder	0.0176	0.1	CbGeAlD
Levomethadyl Acetate—CYP3A4—urine—bipolar disorder	0.0173	0.0984	CbGeAlD
Levomethadyl Acetate—CHRNB4—brain—bipolar disorder	0.0134	0.0767	CbGeAlD
Levomethadyl Acetate—Loperamide—POMC—bipolar disorder	0.012	0.255	CrCbGaD
Levomethadyl Acetate—CYP3A5—blood plasma—bipolar disorder	0.012	0.0684	CbGeAlD
Levomethadyl Acetate—CHRNA3—nervous system—bipolar disorder	0.0108	0.0615	CbGeAlD
Levomethadyl Acetate—CHRNA3—cerebellum—bipolar disorder	0.0102	0.0579	CbGeAlD
Levomethadyl Acetate—Orphenadrine—GRIN1—bipolar disorder	0.00916	0.194	CrCbGaD
Levomethadyl Acetate—CYP3A4—blood plasma—bipolar disorder	0.00901	0.0513	CbGeAlD
Levomethadyl Acetate—CHRNA3—brain—bipolar disorder	0.00825	0.047	CbGeAlD
Levomethadyl Acetate—OPRM1—nervous system—bipolar disorder	0.00657	0.0375	CbGeAlD
Levomethadyl Acetate—CYP19A1—thyroid gland—bipolar disorder	0.00657	0.0374	CbGeAlD
Levomethadyl Acetate—CYP19A1—nervous system—bipolar disorder	0.00552	0.0315	CbGeAlD
Levomethadyl Acetate—OPRM1—brain—bipolar disorder	0.00502	0.0286	CbGeAlD
Levomethadyl Acetate—CYP19A1—brain—bipolar disorder	0.00422	0.0241	CbGeAlD
Levomethadyl Acetate—Propiomazine—DRD4—bipolar disorder	0.00408	0.0865	CrCbGaD
Levomethadyl Acetate—Modafinil—SLC6A3—bipolar disorder	0.00405	0.0858	CrCbGaD
Levomethadyl Acetate—Benzphetamine—SLC6A3—bipolar disorder	0.00351	0.0744	CrCbGaD
Levomethadyl Acetate—Propiomazine—DRD1—bipolar disorder	0.00345	0.0732	CrCbGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.00306	0.00393	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.00303	0.0039	CbGpPWpGaD
Levomethadyl Acetate—Propiomazine—HTR2C—bipolar disorder	0.00295	0.0626	CrCbGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00293	0.00377	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—SNAP25—bipolar disorder	0.00287	0.0037	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00284	0.00366	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00282	0.00363	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00281	0.00361	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00278	0.00358	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—RGS4—bipolar disorder	0.00269	0.00346	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—nervous system—bipolar disorder	0.00268	0.0153	CbGeAlD
Levomethadyl Acetate—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.00264	0.0034	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—SNAP25—bipolar disorder	0.00263	0.00338	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—COMT—bipolar disorder	0.0026	0.00334	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—GRIN2B—bipolar disorder	0.0026	0.00334	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.00258	0.00332	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00256	0.0033	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—SLC6A3—bipolar disorder	0.00256	0.00329	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00254	0.00327	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—ADCY2—bipolar disorder	0.00254	0.00327	CbGpPWpGaD
Levomethadyl Acetate—Propiomazine—DRD2—bipolar disorder	0.00243	0.0516	CrCbGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00241	0.0031	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—GRIN2B—bipolar disorder	0.00238	0.00306	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—SLC6A3—bipolar disorder	0.00234	0.00301	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—ADCY2—bipolar disorder	0.00233	0.00299	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—TACR1—bipolar disorder	0.00229	0.00294	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00223	0.00287	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00218	0.0028	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—COMT—bipolar disorder	0.00218	0.0028	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—MAOA—bipolar disorder	0.00216	0.00278	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—GSK3A—bipolar disorder	0.0021	0.0027	CbGpPWpGaD
Levomethadyl Acetate—Promethazine—DRD2—bipolar disorder	0.00205	0.0435	CrCbGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—COMT—bipolar disorder	0.00199	0.00256	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—MAOA—bipolar disorder	0.00198	0.00254	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00194	0.00249	CbGpPWpGaD
Levomethadyl Acetate—Propiomazine—HTR2A—bipolar disorder	0.00188	0.0399	CrCbGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—TAC1—bipolar disorder	0.00187	0.0024	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00181	0.00233	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Opioid Signalling—POMC—bipolar disorder	0.00177	0.00228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00174	0.00224	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00166	0.00214	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—DRD5—bipolar disorder	0.00166	0.00213	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—HTR1A—bipolar disorder	0.0016	0.00206	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00159	0.00204	CbGpPWpGaD
Levomethadyl Acetate—Promethazine—HTR2A—bipolar disorder	0.00158	0.0336	CrCbGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00157	0.00202	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00154	0.00197	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00154	0.00197	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—DRD3—bipolar disorder	0.00149	0.00192	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—COMT—bipolar disorder	0.00149	0.00191	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00148	0.00191	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—MAOA—bipolar disorder	0.00148	0.0019	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—COMT—bipolar disorder	0.00147	0.00189	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—DRD4—bipolar disorder	0.00145	0.00187	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00143	0.00184	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00143	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00143	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.0014	0.0018	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00139	0.00178	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—ADCY2—bipolar disorder	0.00137	0.00176	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—DRD2—bipolar disorder	0.00135	0.00174	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00135	0.00173	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—COMT—bipolar disorder	0.00129	0.00166	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—MAOA—bipolar disorder	0.00128	0.00165	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—COMT—bipolar disorder	0.00127	0.00164	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—IMPA2—bipolar disorder	0.00127	0.00164	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00127	0.00163	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00125	0.00161	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00125	0.00161	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00123	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00123	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—bipolar disorder	0.00121	0.00156	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—ADM—bipolar disorder	0.0012	0.00154	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00119	0.00153	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00119	0.00153	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—TSHB—bipolar disorder	0.00117	0.0015	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—TACR1—bipolar disorder	0.00117	0.0015	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00115	0.00148	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00114	0.00146	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—IMPA2—bipolar disorder	0.0011	0.00142	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00107	0.00138	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DGKH—bipolar disorder	0.00103	0.00132	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR1A—bipolar disorder	0.000968	0.00124	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000967	0.00124	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—POMC—bipolar disorder	0.000961	0.00124	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—TAC1—bipolar disorder	0.000953	0.00123	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD5—bipolar disorder	0.000938	0.00121	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR2C—bipolar disorder	0.000934	0.0012	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—DRD1—bipolar disorder	0.000934	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—COMT—bipolar disorder	0.000933	0.0012	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DGKH—bipolar disorder	0.000931	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—MAOA—bipolar disorder	0.000927	0.00119	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—COMT—bipolar disorder	0.000921	0.00118	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—RGS4—bipolar disorder	0.000919	0.00118	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—DRD3—bipolar disorder	0.000905	0.00116	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—bipolar disorder	0.000896	0.00115	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000879	0.00113	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—DRD4—bipolar disorder	0.000879	0.00113	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—IMPA1—bipolar disorder	0.000859	0.00111	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD5—bipolar disorder	0.000851	0.0011	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00084	0.00108	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—RGS4—bipolar disorder	0.000835	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—POMC—bipolar disorder	0.000835	0.00107	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—DRD2—bipolar disorder	0.000818	0.00105	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000811	0.00104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—IMPA2—bipolar disorder	0.000799	0.00103	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—bipolar disorder	0.000756	0.000973	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000753	0.000968	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—IMPA1—bipolar disorder	0.000746	0.00096	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NDUFV2—bipolar disorder	0.000731	0.00094	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—TRPC3—bipolar disorder	0.000711	0.000914	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKR1C4—bipolar disorder	0.000708	0.00091	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ADM—bipolar disorder	0.000678	0.000872	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—TSHB—bipolar disorder	0.000661	0.00085	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PDE4B—bipolar disorder	0.000661	0.00085	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—TACR1—bipolar disorder	0.000661	0.00085	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000651	0.000838	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TRPC3—bipolar disorder	0.000645	0.00083	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NR1D1—bipolar disorder	0.000636	0.000818	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NDUFV2—bipolar disorder	0.000635	0.000816	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ADM—bipolar disorder	0.000616	0.000792	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKR1C4—bipolar disorder	0.000615	0.000791	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NCAN—bipolar disorder	0.000608	0.000782	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—POMC—bipolar disorder	0.000603	0.000776	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000601	0.000773	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TSHB—bipolar disorder	0.0006	0.000772	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TACR1—bipolar disorder	0.0006	0.000772	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PDE4B—bipolar disorder	0.0006	0.000772	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKR1C4—bipolar disorder	0.000598	0.000769	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC5A3—bipolar disorder	0.000596	0.000766	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—bipolar disorder	0.000573	0.000737	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NR1D1—bipolar disorder	0.000552	0.00071	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DGKH—bipolar disorder	0.00055	0.000707	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR1A—bipolar disorder	0.000547	0.000703	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—IMPA1—bipolar disorder	0.00054	0.000694	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—TAC1—bipolar disorder	0.000539	0.000693	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000528	0.000679	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000528	0.000679	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD1—bipolar disorder	0.000528	0.000679	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NCAN—bipolar disorder	0.000528	0.000679	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC5A3—bipolar disorder	0.000517	0.000665	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD3—bipolar disorder	0.000511	0.000658	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD5—bipolar disorder	0.000503	0.000647	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR1A—bipolar disorder	0.000497	0.000639	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD4—bipolar disorder	0.000497	0.000639	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RGS4—bipolar disorder	0.000493	0.000634	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TAC1—bipolar disorder	0.000489	0.000629	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD1—bipolar disorder	0.00048	0.000617	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.00048	0.000617	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000467	0.000601	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD3—bipolar disorder	0.000464	0.000597	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000463	0.000595	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NDUFV2—bipolar disorder	0.000459	0.00059	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—POMC—bipolar disorder	0.000458	0.000589	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000451	0.00058	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKR1C4—bipolar disorder	0.000444	0.000571	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000434	0.000558	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000431	0.000554	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CLOCK—bipolar disorder	0.000431	0.000554	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000428	0.000551	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.000424	0.000546	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—DRD2—bipolar disorder	0.00042	0.00054	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TPH2—bipolar disorder	0.00042	0.00054	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TSHB—bipolar disorder	0.00042	0.00054	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CACNB2—bipolar disorder	0.00042	0.00054	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DPYD—bipolar disorder	0.000413	0.000531	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NR1D1—bipolar disorder	0.000399	0.000513	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CACNA1C—bipolar disorder	0.000384	0.000494	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NCAN—bipolar disorder	0.000382	0.000491	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TRPC3—bipolar disorder	0.000381	0.00049	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3C2A—bipolar disorder	0.000374	0.000481	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CLOCK—bipolar disorder	0.000374	0.000481	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC5A3—bipolar disorder	0.000374	0.000481	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000371	0.000478	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000369	0.000475	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TSHB—bipolar disorder	0.000364	0.000469	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TPH2—bipolar disorder	0.000364	0.000469	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CACNB2—bipolar disorder	0.000364	0.000469	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADM—bipolar disorder	0.000364	0.000468	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DPYD—bipolar disorder	0.000359	0.000461	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSHB—bipolar disorder	0.000354	0.000456	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000354	0.000456	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TACR1—bipolar disorder	0.000354	0.000456	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SNAP25—bipolar disorder	0.000336	0.000432	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CACNA1C—bipolar disorder	0.000333	0.000429	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3C2A—bipolar disorder	0.000325	0.000418	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000324	0.000417	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ADCY2—bipolar disorder	0.000297	0.000382	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000294	0.000378	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000293	0.000377	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SNAP25—bipolar disorder	0.000291	0.000375	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TAC1—bipolar disorder	0.000289	0.000372	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000283	0.000364	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD1—bipolar disorder	0.000283	0.000364	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000281	0.000361	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000276	0.000354	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD3—bipolar disorder	0.000274	0.000353	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000273	0.000351	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CLOCK—bipolar disorder	0.00027	0.000348	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD4—bipolar disorder	0.000266	0.000343	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TSHB—bipolar disorder	0.000263	0.000339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TPH2—bipolar disorder	0.000263	0.000339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CACNB2—bipolar disorder	0.000263	0.000339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DPYD—bipolar disorder	0.000259	0.000333	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—POMC—bipolar disorder	0.000259	0.000333	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ADCY2—bipolar disorder	0.000258	0.000332	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—COMT—bipolar disorder	0.000254	0.000327	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MAOA—bipolar disorder	0.000253	0.000325	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000251	0.000323	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000251	0.000322	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.00025	0.000321	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DRD2—bipolar disorder	0.000248	0.000319	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CACNA1C—bipolar disorder	0.000241	0.00031	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—POMC—bipolar disorder	0.000235	0.000302	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	0.000235	0.000302	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NTRK1—bipolar disorder	0.000225	0.000289	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—COMT—bipolar disorder	0.000221	0.000284	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MAOA—bipolar disorder	0.000219	0.000282	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—S100B—bipolar disorder	0.000218	0.000281	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000213	0.000274	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SNAP25—bipolar disorder	0.000211	0.000271	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000207	0.000266	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—bipolar disorder	0.000206	0.000264	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NRG1—bipolar disorder	0.000193	0.000248	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ADCY2—bipolar disorder	0.000186	0.00024	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NR1D1—bipolar disorder	0.000186	0.000239	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—bipolar disorder	0.000178	0.00023	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NCAN—bipolar disorder	0.000177	0.000228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC5A3—bipolar disorder	0.000174	0.000224	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR2A—bipolar disorder	0.000174	0.000224	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—POMC—bipolar disorder	0.000164	0.000211	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—INS—bipolar disorder	0.000163	0.00021	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—COMT—bipolar disorder	0.00016	0.000205	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MAOA—bipolar disorder	0.000159	0.000204	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—POMC—bipolar disorder	0.000143	0.000184	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—INS—bipolar disorder	0.000142	0.000183	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GSK3B—bipolar disorder	0.00014	0.00018	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—POMC—bipolar disorder	0.000139	0.000179	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—INS—bipolar disorder	0.000138	0.000178	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—bipolar disorder	0.000129	0.000166	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CLOCK—bipolar disorder	0.000126	0.000162	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TPH2—bipolar disorder	0.000122	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TSHB—bipolar disorder	0.000122	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CACNB2—bipolar disorder	0.000122	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DPYD—bipolar disorder	0.000121	0.000155	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CACNA1C—bipolar disorder	0.000112	0.000144	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	0.000109	0.00014	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—POMC—bipolar disorder	0.000103	0.000133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—INS—bipolar disorder	0.000103	0.000132	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SNAP25—bipolar disorder	9.79e-05	0.000126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ADCY2—bipolar disorder	8.67e-05	0.000111	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—COMT—bipolar disorder	7.42e-05	9.55e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MAOA—bipolar disorder	7.37e-05	9.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—bipolar disorder	6e-05	7.72e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—POMC—bipolar disorder	4.8e-05	6.17e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INS—bipolar disorder	4.77e-05	6.14e-05	CbGpPWpGaD
